She later presented a recurrent bone marrow involvement treated with intramuscular paromomycin and miltefosine. She died two years later from leukemia. At the time of death, she presented with a mucosal destruction of the nose. [ncbi.nlm.nih.gov]

• Fever

  Due to continual pathological signals in liver and lungs, persistent fever, and an M-component in peripheral blood, a new course of four rituximab doses was given, after which the fever settled, the PET scan normalized, and the M-component disappeared [ncbi.nlm.nih.gov]

• Urinary Urgency

  Adverse reactions: The main adverse reactions affect the gastrointestinal tract (nausea, vomiting, colic, diarrhea) and are dose-dependant with a tendency to improve with time, and the genitourinary system (urinary urgency, polyuria, dysuria, sterile [scielo.br]

• Microscopic Hematuria

  In fact, microscopic-hematuria was resolved in only 16 and 42 % of two-assigned groups in STOP-IgAN, respectively. Okabayashi et al. provided a timely message regarding the significance of immunosuppressive treatment of IgAN. [ncbi.nlm.nih.gov]

Study limitations included small sample size and heterogeneity in age and comparative treatments across the studies. CONCLUSIONS: Cyclosporin-based treatments provided a significantly better partial remission rate as compared with other therapies. [ncbi.nlm.nih.gov]

This study aims to test whether immunosuppressive therapy is effective in reducing the complication of the operation and improve the prognosis. [ncbi.nlm.nih.gov]

ZAP70 is also overexpressed in some individuals with chronic lymphocytic leukaemia, and these individuals have an especially poor prognosis. ZAP70 might therefore also be a useful therapeutic target in these patients. [ebi.ac.uk]

We conclude that in children without a MSD treatment with combined IST and G-CSF converts the former bad prognosis factor severe granulocytopenia into an indicator of better response and survival. [bloodjournal.org]

Whether anti-GAD antibodies have an etiological role in these neurological disorders or simply serve as disease markers is unclear. [ncbi.nlm.nih.gov]

Spallanzani, Rome, Italy. 5 Unit of Clinical Epidemiology, IRCCS INMI L. Spallanzani, Rome, Italy. 6 Department of Cardiac Surgery, European Hospital, Rome, Italy. [ncbi.nlm.nih.gov]

Reasons to buy Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options for transplantation rejection. [globenewswire.com]

Carr AS, Cardwell CR, McCarron PO, McConville J: A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol 2010; 18: 10-46 2. Fleury MC, Tranchant C: Myasthenia gravis. Rev Prat 2008; 58: 2217-2224 3. [arastirmax.com]

Epidemiology of aplastic anemia: A prospective multicenter study. Haematologica. 2008;93(4):518–23. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood J. 2006;108(8):2509–20. [jurnal.unissula.ac.id]

In addition, the epidemiology of infections after solid organ transplantation has shifted as a result of changes in immunosuppressive strategies and improved survival. [kiss.kstudy.com]

Abnormal cytotoxic T-cell activation with cytokine release is a possible pathophysiology. We present the case of a 16-month-old Japanese male who developed HAAA following living-donor liver transplantation for fulminant hepatitis. [ncbi.nlm.nih.gov]

Aplastic Anemia : Pathophysiology and Treatment. Biol Blood Marrow Transplant. 2010;16(1):S119–25. Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H. [jurnal.unissula.ac.id]

Favor First-in-Class Product Innovation 3.5 Sustained Innovation 3.6 Research Report Guidance 4 Clinical and Commercial Landscape 4.1 Disease Overview 4.2 Symptoms 4.2.1 Transplant Rejection 4.2.2 Graft-Versus-Host Disease 4.3 Diagnosis 4.4 Etiology and Pathophysiology [globenewswire.com]

To prevent rejection of the transplanted organ, HT patients require life-long immunosuppressive therapy. The goal of the immunosuppression is to minimise the risk of immune-mediated graft rejection, while avoiding clinical side-effects. [ncbi.nlm.nih.gov]